(Q81039508)
English
A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a
scientific article published on 04 September 2007
Statements
A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer (English)
Y Bécouarn
P Senesse
S Thézenas
E Boucher
A Adenis
L Cany
J H Jacob
F Cvitkovic
C Montoto-Grillot
Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer